Medical device maker Medtronic is looking at options to modify its global manufacturing footprint as part of efforts to ...

Medtronic (MDT) is reportedly looking at adjusting its global manufacturing footprint amid heightened concerns that the U.S.

Medtronic said Monday the U.S. Food and Drug Administration has approved an adaptive brain-stimulation device as a treatment ...

The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with ...

After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Charles Schwab Corp. (SCHW), ...

The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...

Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by ...

Medtronic's agnostic approach to global challenges, including tariffs and AI, ensures success and innovation in healthcare ...

The company's adaptive deep brain stimulation technology for Parkinson's disease therapy is expected to be available ...

The BrainSense Adaptive technology is an enhancement to Medtronic’s Percept DBS neurostimulators. The advancement ...

(NYSE: MDT) announced today that the FDA approved its BrainSense adaptive deep brain stimulation (aDBS) platform.